middle.news

Botanix Pharmaceuticals Launches Sofdra, Eyes Revenue Surge in 2025

6:24pm on Sunday 1st of June, 2025 AEST Pharmaceuticals
Read Story

Botanix Pharmaceuticals Launches Sofdra, Eyes Revenue Surge in 2025

6:24pm on Sunday 1st of June, 2025 AEST
Key Points
  • First Sofdra prescriptions issued and 100% refill rate achieved
  • Full commercial launch underway with 27 trained territory managers
  • Contracts secured with key US commercial and government payers covering 247 million lives
  • Q1 2025 expected to deliver first commercial revenue quarter, with Q2 revenue ramp anticipated
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about BOT
OPEN ARTICLE